Organic/Inorganic Species Synergistically Supported Unprecedented Vanadomolybdates

Vanadomolybdates (VMos), comprised of Mo and V in high valences with O bridges, are one of the most important types of polyoxometalates (POMs), which have high activity due to their strong capabilities of gaining/losing electrons. Compared with other POMs, the preparation of VMos is difficult due to their relatively low structural stability, especially those with unclassical architectures. To overcome this shortcoming, in this study, triol ligands were applied to synthesize VMos through a beaker reaction in the presence of V₂O₅, Na₂MoO₄, and organic species in the aqueous solution. The single-crystal X-ray diffraction results indicate that two VMo clusters, Na₄{V₅Mo₂O₁₉[CH₃C(CH₂O)₃]}∙13H₂O and Na₄{V₅Mo₂O₁₉[CH₃CH₂C(CH₂O)₃]}∙13H₂O, with a similar architecture, were synthesized, which were both stabilized by triol ligand and {MoO₆} polyhedron. Both clusters are composed of five V ions and one Mo ion in a classical Lindqvist arrangement with an additional Mo ion, showing an unprecedented hepta-nuclear VMo structure. The counter Na⁺ cations assemble into one-dimensional channels, which facilitates the transport of protons and was further confirmed by proton conductivity experiments. The present results provide a new strategy to prepare and stabilize VMos, which is applicable for developing other compounds, especially those with untraditional architectures.     

Magnolol as a Potential Anticancer Agent: A Proposed Mechanistic Insight

Cancer is a serious disease with high mortality and morbidity worldwide. Natural products have served as a major source for developing new anticancer drugs during recent decades. Magnolol, a representative natural phenolic lignan isolated from Magnolia officinali, has attracted considerable attention for its anticancer properties in recent years. Accumulating preclinical studies have demonstrated the tremendous therapeutic potential of magnolol via a wide range of pharmacological mechanisms against cancer. In this review, we summarized the latest advances in preclinical studies investigating anticancer properties of magnolol and described the important signaling pathways explaining its underlying mechanisms. Magnolol was capable of inhibiting cancer growth and metastasis against various cancer types. Magnolol exerted anticancer effects through inhibiting proliferation, inducing cell cycle arrest, provoking apoptosis, restraining migration and invasion, and suppressing angiogenesis. Multiple signaling pathways were also involved in the pharmacological actions of magnolol against cancer, such as PI3K/Akt/mTOR signaling, MAPK signaling and NF-κB signaling. Based on this existing evidence summarized in the review, we have conclusively confirmed magnolol had a multi-target anticancer effect against heterogeneous cancer disease. It is promising to develop magnolol as a drug candidate for cancer therapy in the future.     

Design,Synthesis and Biological Evaluation of Novel and Potent Protein Arginine Methyltransferases 5 Inhibitors for Cancer Therapy

Protein arginine methyltransferases 5 (PRMT5) is a clinically promising epigenetic target that is upregulated in a variety of tumors. Currently, there are several PRMT5 inhibitors under preclinical or clinical development, however the established clinical inhibitors show favorable toxicity. Thus, it remains an unmet need to discover novel and structurally diverse PRMT5 inhibitors with characterized therapeutic utility. Herein, a series of tetrahydroisoquinoline (THIQ) derivatives were designed and synthesized as PRMT5 inhibitors using GSK-3326595 as the lead compound. Among them, compound 20 (IC₅₀: 4.2 nM) exhibits more potent PRMT5 inhibitory activity than GSK-3326595 (IC₅₀: 9.2 nM). In addition, compound 20 shows high anti-proliferative effects on MV-4-11 and MDA-MB-468 tumor cells and low cytotoxicity on AML-12 hepatocytes. Furthermore, compound 20 possesses acceptable pharmacokinetic profiles and displays considerable in vivo antitumor efficacy in a MV-4-11 xenograft model. Taken together, compound 20 is an antitumor compound worthy of further study.     

全自动固相萃取技术同时测定动物产品中9种磺胺药物残留

针对目前动物产品中兽药残留检测样品前处理繁琐的问题,应用全自动固相萃取技术对动物产品中9种磺胺类药物残留检测的样品前处理方法进行了系统的研究,对提取溶剂、固相萃取柱、淋洗液、洗脱溶剂及仪器分析条件进行了优化选择,建立了新型磺胺药物残留检测的全自动固相萃取净化方法.经不同检测单位验证,该方法的加标回收率为78.4%～107.8%,精密度为3.9%～11.0%检出限为0.010～0.020mg/kg,满足出口检测要求.     

铜丝电爆炸的光谱分析

通过搭建脉冲成形网络放电模块和光谱测试系统,利用Andor SR750光谱仪测量了铜丝电爆炸等离子体在400~500nm范围内的发射光谱。根据热力学平衡理论,采用双谱线相对强度法计算了等离子体的激发温度,并研究了激发温度随时间变化的特性。研究结果表明,铜丝电爆炸产生的稳态等离子体的激发温度约为5 400K。在脉冲放电前期,激发温度变化较大;在放电后期,激发温度较稳定;整个脉冲时间内激发温度差约达800K。

     

Ka波段宽带谐波抑制定向耦合器

为解决传统分支线定向耦合器带宽较窄,且应用到线性化器等微波元件中时受谐波信号影响较大的问题,提出了一个宽带且带有谐波抑制功能的定向耦合器。该定向耦合器在双支节定向耦合器的基础上增加一个支节,可有效地提高定向耦合器的带宽,同时将其传输线支节替换为低通滤波结构,以实现对高次谐波抑制的作用。仿真结果表明,该定向耦合器的反射系数和隔离度均小于-15 dB,传输损耗小于3.8 dB,波动范围0.5 dB,相位差为90°且与双支节耦合器相比增加1 GHz带宽。满足耦合器的设计指标,可应用到微波元件中,提高微波元件的性能。     

太赫兹自由电子激光光腔光子晶体镜的设计

利用传输矩阵法对太赫兹自由电子激光光腔光子晶体镜进行了模拟设计,中心波段在1~3 THz。对光腔镜的光子晶体结构参数如介质厚度、层数、折射率与反射率的关系等进行了研究,并给出了一维光子晶体用于高反镜的设计方法。通过对耦合输出镜光子晶体中引入缺陷层情况的数值模拟,发现通过对缺陷层的调节设计,可以实现耦合输出率的可调谐;并给出了可用于THz 自由电子激光光腔耦合输出镜的调节方法。通过对介质层厚度的调节设计,可以实现反射光谱的整体移动,从而实现宽谱可调谐,扩大了高反镜及耦合输出镜的调节范围。     

New lead-iodide formates with a strong second-harmonic generation response and suitable birefringence obtained by the substitution strategy

Nonlinear optical (NLO) crystals featuring a strong second-harmonic generation (SHG) response and suitable birefringence to achieve phase-matching are in urgent demand in industrial and commercial applications. Based on the substitution strategy, two new NLO lead-iodide formates, K₂[PbI₂(HCOO)₂] and Rb₂[PbI₂(HCOO)₂], have been successfully synthesized using a moderate mixed-solvothermal method. K₂[PbI₂(HCOO)₂] and Rb₂[PbI₂(HCOO)₂] exhibit strong phase-matching SHG responses of 8 and 6.8 × KDP, respectively, a suitable birefringence and transparent window covering most of the visible light and mid-IR region. Crystal structures and theoretical calculations unveil that the origins of the strong SHG response and suitable birefringence can be credibly attributed to the oriented arrangement of the highly distorted [PbI₂O₄] hexa-coordinated polyhedra, which are consistent in their local dipole moments, as well. This research provides a new strategy to explore high-performance NLO crystals.

K₂[PbI₂(HCOO)₂] and Rb₂[PbI₂(HCOO)₂] with highly distorted [PbI₂O₄] polyhedra in an oriented arrangement exhibit a very strong phase-matching SHG response, suitable birefringence, wide transparent windows and good thermal stability.     

pH and Salt-Assisted Macroscopic Chirality Inversion of Gadolinium Coordination Polymer

The precise adjustment of handedness of helical architectures is important to regulate their functions. Macroscopic chirality inversion has been achieved in organic supramolecular systems by pH, metal ions, solvents, chiral and non-chiral additives, temperature, and light, but rarely in coordination polymers (CPs). In particular, salt-assisted macroscopic chirality inversion has not been reported. In this work, we carried out a systematic investigation on the role of pH and salt in regulating the morphology of CPs based on Gd(NO₃)₃ and R-(1-phenylethylamino)methylphosphonic acid (R-pempH₂). Without extra NO₃⁻, the chirality inversion from the left-handed superhelix R-M to the right-handed superhelix R-P can be achieved by pH modulation from 3.2 to 3.8. The addition of NaNO₃ (2.0 eq) at pH 3.8 results in an inversion of chiral sense from R-P to R-M as a pure phase. To our knowledge, this is the first example of salt-assisted macroscopic helical inversion in artificial systems.